The startup develops a medical analysis and imaging system that utilizes artificial intelligence to predict treatment responses in brain cancer patients by integrating genomic data with clinical outcomes. This technology enhances the effectiveness of radiation therapy while minimizing associated risks for medical practitioners.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Radiation therapy planning for cancer patients is a complex and time-consuming process, often requiring manual delineation of anatomical regions on 3D images. This manual process can lead to variability and inefficiencies, potentially impacting the precision and effectiveness of the treatment. Furthermore, integrating different imaging modalities like MRI and CT adds complexity and potential for registration errors.
Solution
TheraPanacea offers an AI-powered radiotherapy treatment planning software, ART-Plan, designed to optimize each step of the treatment process, from preparation to follow-up. The software suite includes modules for automatic delineation (Annotate), image fusion (SmartFuse), pseudo-CT generation from MR images (MR-Box), and adaptive planning (AdaptBox). By leveraging AI, TheraPanacea's solutions aim to reduce contouring time, improve accuracy, streamline workflows, and facilitate personalized and effective cancer care. The platform supports multiple imaging modalities, including CT, MRI, CBCT, and PET-CT, and is designed to integrate seamlessly into existing clinical workflows.
Target Audience
TheraPanacea's solutions are designed for radiation oncologists, radiologists, neurologists, and other medical professionals involved in cancer treatment planning and delivery, as well as research and development teams focused on personalized medicine.
Features
- **Annotate:** AI-based software for automatic delineation of anatomical regions on 3D images, supporting various anatomical sites, including head & neck, thorax/breast, heart, lung, and pelvis.
- **SmartFuse:** AI-initiated rigid and deformable image fusion, enabling real-time deformation of contours and sub-voxel registration accuracy across multiple imaging modalities.
- **MR-Box:** AI-powered generation of pseudo-CT images from MR images, eliminating the need for multi-modal registration and streamlining MR-only workflows.
- **AdaptBox:** AI-enhanced tool for adaptive planning, generating augmented CBCT images and facilitating daily dose tracking for more personalized replanning decisions.
- **ART-Plan:** A web-based solution for radiotherapy, optimizing the treatment process from preparation to follow-up.
- Integrates with existing treatment planning systems (TPS) and linear accelerators (Linac).
- Supports DICOM standards for seamless data exchange.
- AI-powered OARs (organs at risk) delineation on MR images.